ABOUT CARESYNTAX
The world-leading developer
of surgical intelligence and
automation technologies
WHO WE ARE
Making Surgery Safer and Smarter
At Caresyntax, we are dedicated to making surgery safer and smarter. Our mission is to converge AI-powered software, devices, and clinical services to help our customers improve surgical outcomes. Our platform, an enterprise-grade surgical intelligence system, is vendor-neutral and equipped with proprietary software, hardware, and advanced AI capabilities. It can ingest and analyze data throughout the surgical workflow, including EMR, video, audio, image, device data, financial and outcomes data, and clinical and operational metrics to capture a complete picture of the surgical pathway.
The platform generates insights across the entire continuum of care—before the procedure with surgical workflow optimization, during surgery with real-time clinically relevant support tools, and post procedure with clinical safety modules. The platform also produces data analytics and insights for medical device companies, insurers, and other ecosystem players to innovate and drive the future of healthcare delivery.
Headquartered in the US in San Francisco and internationally in Berlin, Caresyntax software is used in over 3,000 ORs globally and aids surgical teams in over 3 million procedures annually.
PSO
Caresyntax is a PSO
Caresyntax offers an AHRQ-listed Patient Safety Organization (PSO). PSOs help address barriers to quality and patient safety improvement, specifically the protected sharing of confidential quality information across healthcare organizations. PSOs provide federal protections which are more comprehensive than state laws, allowing provider quality and safety information to be confidentially shared across sites and organizations.
The Caresyntax PSO is dedicated to leveraging data collected from its members to reduce surgical variability and accelerate improvements in patient safety outcomes, quality of care, and operational efficiency.
PARTNERS
Caresyntax and Intel are combining their capabilities to develop new breakthrough technologies to transform surgery, further enhancing Caresyntax’s data-driven surgery platform and addressing key problems in surgery. As part of the collaboration, Caresyntax will utilize Intel’s expertise in artificial intelligence (AI) applications to develop solutions that address the acute surgery staffing shortage: The Caresyntax Personalized Surgical Playbook and turn-by-turn guidance functionality for operating room staff, powered by Intel technologies, enable rapid onboarding of new clinicians and travel nurses. Turn-by-turn guidance in the operating room is designed to help surgical staff support the surgeon during each turn or phase of the procedure. In addition, Intel Capital is an investor in Caresyntax.
World Economic Forum Global Innovators Community
Caresyntax has joined the World Economic Forum’s (WEF) Global Innovators Community as part of the WEF Unicorn track. The Global Innovators Community is an invitation-only group of the world’s most promising start-ups and scale-ups that are at the forefront of ethical technological and business model innovation. As part of the WEF Community’s Health and Healthcare platform, Caresyntax will work with other community members to advance global healthcare transformation.